DK1066041T3 - Anvendelse af 17-alpha-estradiol derivater til terapi af bivirkninger under og/eller efter en GnRHa-terapi - Google Patents

Anvendelse af 17-alpha-estradiol derivater til terapi af bivirkninger under og/eller efter en GnRHa-terapi

Info

Publication number: DK1066041T3
Authority: DK; Denmark
Prior art keywords: therapy; alpha; side effects; gnrha; estradiol
Prior art date: 1998-04-03

Application number

DK99907318T

Other languages

English (en)

Inventor

Michael Oettel

Ludwig Wildt

Joachim Neuwinger

Peter Licht

Ralph Dittrich

Wolfgang Hummel

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-03

Filing date

1999-02-10

Publication date

2006-03-27

1999-02-10 Application filed by Schering Ag filed Critical Schering Ag

2006-03-27 Application granted granted Critical

2006-03-27 Publication of DK1066041T3 publication Critical patent/DK1066041T3/da

Links

238000002560 therapeutic procedure Methods 0.000 title abstract 3
230000000694 effects Effects 0.000 title abstract 2
150000000304 17α-estradiols Chemical class 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 2
PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Chemical class OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
229930182834 17alpha-Estradiol Natural products 0.000 abstract 1
VOXZDWNPVJITMN-SFFUCWETSA-N 17α-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-SFFUCWETSA-N 0.000 abstract 1
150000000307 17β-estradiols Chemical class 0.000 abstract 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 abstract 1
206010060800 Hot flush Diseases 0.000 abstract 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
229960001348 estriol Drugs 0.000 abstract 1
PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical class OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 abstract 1
229940035638 gonadotropin-releasing hormone Drugs 0.000 abstract 1
238000007918 intramuscular administration Methods 0.000 abstract 1
238000007912 intraperitoneal administration Methods 0.000 abstract 1
238000001990 intravenous administration Methods 0.000 abstract 1
238000007920 subcutaneous administration Methods 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)

DK99907318T 1998-04-03 1999-02-10 Anvendelse af 17-alpha-estradiol derivater til terapi af bivirkninger under og/eller efter en GnRHa-terapi DK1066041T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19815060A DE19815060A1 (de)	1998-04-03	1998-04-03	Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie

Publications (1)

Publication Number	Publication Date
DK1066041T3 true DK1066041T3 (da)	2006-03-27

Family

ID=7863548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99907318T DK1066041T3 (da)	1998-04-03	1999-02-10	Anvendelse af 17-alpha-estradiol derivater til terapi af bivirkninger under og/eller efter en GnRHa-terapi

Country Status (8)

Country	Link
EP (1)	EP1066041B1 (da)
JP (1)	JP3925688B2 (da)
AT (1)	ATE308986T1 (da)
AU (1)	AU2712799A (da)
DE (2)	DE19815060A1 (da)
DK (1)	DK1066041T3 (da)
ES (1)	ES2252931T3 (da)
WO (1)	WO1999051243A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19906159A1 (de) *	1999-02-09	2000-08-10	Schering Ag	16-Hydroxyestratriene als selektiv wirksame Estrogene
WO2005063276A1 (en) *	2003-12-23	2005-07-14	Debiopharm S.A.	Methods and compositions using gonadotropin hormone releasing hormone
EP3518933B2 (en)	2016-09-30	2025-02-26	Sumitomo Pharma Switzerland GmbH	Methods of treating uterine fibroids and endometriosis
BR112022023937A2 (pt)	2020-05-29	2022-12-27	Myovant Sciences Gmbh	Formas de dosagem oral sólidas de combinação de antagonistas do hormônio liberador de gonadotropina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223261A (en) *	1988-02-26	1993-06-29	Riker Laboratories, Inc.	Transdermal estradiol delivery system
US5043331A (en) *	1989-06-15	1991-08-27	Orion-Yhtyma Oy	Treatment of postmenopausal disorders
US5130137A (en) *	1989-08-09	1992-07-14	The General Hospital Corporation	Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
AR246186A1 (es) *	1989-11-17	1994-07-29	Beta Pharm Co	Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DK0472725T3 (da) *	1990-03-16	1997-11-03	Applied Research Systems	Behandling af polycystisk ovariesygdom
AU8166191A (en) *	1990-08-10	1992-02-13	Ortho Pharmaceutical Corporation	Method for treatment of bone wasting diseases
US5340585A (en) *	1991-04-12	1994-08-23	University Of Southern California	Method and formulations for use in treating benign gynecological disorders
CN1208412A (zh) *	1995-12-14	1999-02-17	麦克公司	促性腺激素释放激素拮抗剂

1998
- 1998-04-03 DE DE19815060A patent/DE19815060A1/de not_active Withdrawn
1999
- 1999-02-10 WO PCT/DE1999/000355 patent/WO1999051243A1/de not_active Ceased
- 1999-02-10 ES ES99907318T patent/ES2252931T3/es not_active Expired - Lifetime
- 1999-02-10 AT AT99907318T patent/ATE308986T1/de not_active IP Right Cessation
- 1999-02-10 EP EP99907318A patent/EP1066041B1/de not_active Expired - Lifetime
- 1999-02-10 AU AU27127/99A patent/AU2712799A/en not_active Abandoned
- 1999-02-10 DE DE59912770T patent/DE59912770D1/de not_active Expired - Fee Related
- 1999-02-10 JP JP2000542014A patent/JP3925688B2/ja not_active Expired - Fee Related
- 1999-02-10 DK DK99907318T patent/DK1066041T3/da active

Also Published As

Publication number	Publication date
WO1999051243A1 (de)	1999-10-14
EP1066041A1 (de)	2001-01-10
JP3925688B2 (ja)	2007-06-06
ES2252931T3 (es)	2006-05-16
JP2002510637A (ja)	2002-04-09
EP1066041B1 (de)	2005-11-09
AU2712799A (en)	1999-10-25
DE59912770D1 (de)	2005-12-15
DE19815060A1 (de)	1999-10-14
ATE308986T1 (de)	2005-11-15

Similar Documents

Publication	Publication Date	Title
ATE215081T1 (de)	2002-04-15	Gonadotropin releasing hormon- antagonisten
NO20040968L (no)	2004-05-05	Opioidagonistpreparater med frigjorbar og sekvestrert antagonist
PL357944A1 (en)	2004-08-09	Intradermal-penetration agents for topical local anesthetic administration
NZ325060A (en)	2000-02-28	Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
NZ326331A (en)	2000-01-28	Heterocycle-condensed morphinoid derivatives and medicaments
EP1129089A4 (en)	2003-01-22	SPIRO-INDOLE AS Y5 RECEPTOR ANTAGONISTS
DK1135153T3 (da)	2005-08-15	Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
DE60143393D1 (de)	2010-12-16	Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
MX9804850A (es)	1998-09-30	Antagonistas de hormona liberadora de gonadotropina.
TR200201874T2 (tr)	2002-10-21	Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
BR0112160A (pt)	2003-10-07	Agentes antiinflamatórios seletivos para glicocorticóides
YU92102A (sh)	2006-01-16	Metode i smeše za lečenje virusnog hepatitisa c
MY129356A (en)	2007-03-30	Electrospun pharmaceutical compositions
EP1007013A4 (en)	2001-08-29	PARENTERAL PIMARICIN FOR TREATING SYSTEMIC INFECTIONS
ATE254927T1 (de)	2003-12-15	Antagonisten der endothelinwirkung
DE69932510D1 (de)	2006-09-07	Vaskularisierungsinhibitoren
ATE272628T1 (de)	2004-08-15	Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DE69911023D1 (de)	2003-10-09	Antagonisten des gonadotropin freisetzenden hormons
DE69927582D1 (de)	2006-02-16	Neue analoga von 16-hydroxyeicosatetraensäure
DK1066041T3 (da)	2006-03-27	Anvendelse af 17-alpha-estradiol derivater til terapi af bivirkninger under og/eller efter en GnRHa-terapi
TR199800478T1 (xx)	1998-06-22	Diarilalkenilamin t�revleri
ES2162433T3 (es)	2001-12-16	Procedimiento para el tratamiento del clinker de cemento.
BR0116552A (pt)	2004-02-03	Hemi-maleato de amlodipina, processo, método para o tratamento ou prevenção de angina ou hipertensão, composição farmacêutica, para uso no tratamento e/ou de angina ou da hipertensão
DK1265856T3 (da)	2004-07-05	Hidtil ukendt fremgangsmåde til fremstillingen af alpha-(2,4-disulfophenyl)-N-tert-butylnitron og farmaceutisk acceptable salte deraf
BR0102150A (pt)	2002-03-12	Isoxazol-sulfonamidas antagonistas de endotelina